Acadian Asset Management LLC boosted its stake in Danaher Corporation (NYSE:DHR) by 39.6% during the second quarter, Holdings Channel reports. The institutional investor owned 1,491,125 shares of the conglomerate’s stock after buying an additional 422,747 shares during the period. Acadian Asset Management LLC’s holdings in Danaher Corporation were worth $125,838,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Fox Run Management L.L.C. boosted its position in Danaher Corporation by 48.9% in the first quarter. Fox Run Management L.L.C. now owns 7,000 shares of the conglomerate’s stock valued at $599,000 after buying an additional 2,300 shares in the last quarter. Regent Investment Management LLC boosted its position in Danaher Corporation by 198.5% in the first quarter. Regent Investment Management LLC now owns 21,322 shares of the conglomerate’s stock valued at $1,824,000 after buying an additional 14,179 shares in the last quarter. OLD Second National Bank of Aurora boosted its position in Danaher Corporation by 50.1% in the first quarter. OLD Second National Bank of Aurora now owns 24,861 shares of the conglomerate’s stock valued at $2,127,000 after buying an additional 8,301 shares in the last quarter. First United Bank Trust boosted its position in Danaher Corporation by 2.9% in the first quarter. First United Bank Trust now owns 25,285 shares of the conglomerate’s stock valued at $2,163,000 after buying an additional 715 shares in the last quarter. Finally, Howland Capital Management LLC boosted its position in Danaher Corporation by 0.4% in the first quarter. Howland Capital Management LLC now owns 247,448 shares of the conglomerate’s stock valued at $21,164,000 after buying an additional 932 shares in the last quarter. 76.12% of the stock is owned by hedge funds and other institutional investors.
Danaher Corporation (DHR) traded up 0.37% during mid-day trading on Friday, hitting $81.21. 1,245,731 shares of the stock traded hands. The stock has a 50 day moving average price of $82.41 and a 200 day moving average price of $84.22. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The firm has a market cap of $56.42 billion, a PE ratio of 25.92 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the previous year, the firm earned $0.90 EPS. Danaher Corporation’s revenue was up 6.3% on a year-over-year basis. On average, analysts expect that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/08/18/acadian-asset-management-llc-has-125-84-million-stake-in-danaher-corporation-dhr.html.
Several research analysts recently issued reports on DHR shares. Vetr raised shares of Danaher Corporation from a “buy” rating to a “strong-buy” rating and set a $94.18 price target for the company in a report on Thursday, April 20th. Royal Bank Of Canada reissued a “sector perform” rating and set a $88.00 price target (down from $89.00) on shares of Danaher Corporation in a report on Friday, April 21st. Zacks Investment Research cut shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Friday, April 21st. BTIG Research reissued a “buy” rating and set a $92.00 price target on shares of Danaher Corporation in a report on Sunday, April 23rd. Finally, Cowen and Company reissued an “outperform” rating and set a $90.00 price target on shares of Danaher Corporation in a report on Sunday, April 23rd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. Danaher Corporation has an average rating of “Buy” and an average price target of $91.76.
In related news, insider William King sold 7,458 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the sale, the insider now directly owns 18,245 shares in the company, valued at approximately $1,513,787.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the sale, the insider now owns 155,520 shares in the company, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders have sold a total of 38,623 shares of company stock worth $3,206,426 over the last 90 days. 12.20% of the stock is owned by insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.